comparemela.com

Latest Breaking News On - முதுகெலும்பு தண்டு சேதம் - Page 9 : comparemela.com

Increasing plant-based offerings at hospitals can improve community health outcomes

Hospitals have a responsibility to continually improve quality of care, and offering nourishing, plant-based meals and medical food options are critical for enhancing patient outcomes, reducing health care costs, and lowering the risk of chronic diseases among its community.

Coverage parity for mental health, substance abuse, a key focus for insurance regulators

Health insurers are prohibited from placing unfavorable limits on mental health and substance abuse benefits, and yet, many do. Federal and state regulators are taking aim at these practices and making the enforcement of the Mental Health Parity and Addiction Equity Act of 2008 a key focus.

Scynexis antifungal drug secures FDA nod; first approval in new class in 20 years

The FDA has approved Brexafemme, a Scynexis antifungal drug, for treating vaginal yeast infections. The drug is the biotech’s first FDA-approved product and it also represents the first new antifungal drug class in 20 years.

Direct-to-consumer startup Thirty Madison targets a new customer: health plans

Direct-to-consumer startup Thirty Madison targets a new customer: health plans Direct-to-consumer startup Thirty Madison targets a new customer: health plans The startup, which currently has four direct-to-consumer brands, recently passed a $1 billion valuation. It plans to use the funds to market its services to a new customer: health plans.  Shares0 As investors continue to pour funds into direct-to-consumer health startups, one of them, Thirty Madison, is looking to win over a new type of customer.  The startup recently raised $140 million in funding, and plans to use a portion of that to strike partnerships with employers and payers.  In an emailed statement, CEO and Co-Founder Steven Gutentag said working with employer and payor networks would allow the company to reach more patients and expand its treatment offerings. The company didn’t disclose which, and how many, partners Thirty Madison currently has. 

Bettina Hein, Author at MedCity News

Bettina Hein Bettina Hein is CEO and Co-Founder of juli, an app that uses AI to help people manage their chronic conditions by surfacing behavioral triggers that encourage healthy decisions. A serial software entrepreneur, Hein has built successful technology companies in Europe and the US. She is founder and past CEO of Pixability, a Boston-based company that provides data-driven insights, precise targeting technology, and social video expertise to help marketers find and engage their audiences across YouTube, Facebook, Instagram, Twitter, and Snapchat. She also co-founded SVOX AG, a Switzerland-based embedded speech technology company that was acquired in 2011 by Nuance Communications for $125M. Hein is a Young Global Leader at the World Economic Forum, and a judge on the Swiss version of TV’s “Shark Tank.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.